Tag: Cagrilintide/semaglutide

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cagrilintide/semaglutide

Where Roche's obesity data fit in efficacy landscape - BioCentury

Added to Collection on: 2024-05-16 19:18:14

Tags for this article:

Peptide hormones
PEPTIDE THERAPEUTICS
Semaglutide
GLP-1 receptor agonist
Tirzepatide
Glucagon-like peptide-1
Novo Nordisk
Ro
Eli Lilly and Company
Cagrilintide/semaglutide
Novo Nordisk A/S

Click the tags to see associated articles and topics

View Article Details
Roche targets obesity market with early positive trial data

Added to Collection on: 2024-05-16 14:42:15

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
CT-868
Novo Nordisk
Glucagon-like peptide-1
Tirzepatide
Eli Lilly and Company
Obesity
Cagrilintide/semaglutide
Semaglutide

Click the tags to see associated articles and topics

View Article Details
Pfizer Advances Oral GLP-1 Development as the Race for Second-Gen Obesity Therapies Continues

Added to Collection on: 2024-07-12 16:42:13

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Semaglutide
GLP-1 receptor agonist
Cagrilintide/semaglutide
Anti-obesity medication
Retatrutide
Tirzepatide
Glucagon-like peptide-1
Orforglipron
Eli Lilly and Company
Novo Nordisk
Glucagon-Like Peptide 1

Click the tags to see associated articles and topics

View Article Details
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades - The Globe and Mail

Added to Collection on: 2024-12-28 13:32:13

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
Eli Lilly and Company
Research and development in the United States
Novo Nordisk
GLP-1 receptor agonist
Semaglutide
Tirzepatide
Eli Lilly
Anti-obesity medication
Insulin
Cagrilintide/semaglutide

Click the tags to see associated articles and topics

View Article Details
Eli Lilly, Novo Nordisk Went Head-to-Head on Weight-Loss Drugs in 2024. There's a Clear Winner.

Added to Collection on: 2024-12-31 14:53:12

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
GLP-1 receptor agonist
Eli Lilly and Company
Novo Nordisk
Cagrilintide/semaglutide
Tirzepatide
Glucagon-like peptide-1
Anti-obesity medication
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk's high-dose Wegovy increases weight loss and remains safe

Added to Collection on: 2025-01-21 00:19:18

Tags for this article:

PEPTIDE THERAPEUTICS
Peptide hormones
In Denmark
In science
Semaglutide
Novo Nordisk
Management of obesity
Cagrilintide
Weight loss
Type 2 diabetes
Cagrilintide/semaglutide
Anti-obesity medication
Novo Nordisk A/S

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk's obesity drug CagriSema disappoints again - European Biotechnology

Added to Collection on: 2025-03-10 20:23:08

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Cagrilintide/semaglutide
Semaglutide
Anti-obesity medication
Tirzepatide
Cagrilintide
Glucagon-like peptide-1
Novo Nordisk
Obesity
Amylin
Novo Nordisk A/S

Click the tags to see associated articles and topics

View Article Details